Global Dermal Necrosis Treatment Market Size, Status and Forecast 2021-2027

皮膚壊死治療の世界市場規模・現状・予測2021年-2027年

◆タイトル:Global Dermal Necrosis Treatment Market Size, Status and Forecast 2021-2027
◆商品コード:QY21APR1802
◆調査・発行会社:QYResearch
◆発行日:2021年4月
◆ページ数:96
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、主要地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥444,600見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥666,900見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥889,200見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査資料では、皮膚壊死治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(免疫抑制剤、コルチコステロイド)、用途別市場規模(病院、クリニック、外来手術センター)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・皮膚壊死治療の市場動向
・企業の競争状況、市場シェア
・皮膚壊死治療の種類別市場規模(免疫抑制剤、コルチコステロイド)
・皮膚壊死治療の用途別市場規模(病院、クリニック、外来手術センター)
・皮膚壊死治療の北米市場規模2016-2027(アメリカ、カナダ)
・皮膚壊死治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・皮膚壊死治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・皮膚壊死治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・皮膚壊死治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Baxter、Boston Therapeutics、Amgen、AstraZeneca、Glaxo Smithkline Pharmaceuticals、Systopic Laboratories、Sun Pharmaceuticals、RPG Life Sciences、Zydus Cadila)
・結論

Acute cutaneous necrosis can be defined as a skin disease with sudden onset of tissue death that results in significant morbidity and is usually, but not always, excruciatingly painful. Early diagnosis can allow for early therapy and can decrease the chances of morbidity and loss of life. A thorough history is mandatory including recent reavel, drugs, underlying illnesses and recent surgical procedures. Blood tests that are often helpful are creatinine phosphokinase, blood cultures, antinuclear antibodies, rheumatoid factor, antinuclear cytoplasmic antibodies, hypercoagulability screen, creatinine, complete blood count and human immunodeficiency virus test. Other procedures such as computerized axial tomography and magnetic resonance imaging also helps to determine the extent of disease.
The dermal necrosis market is expected to witness growth as it is a highly undiscovered area. Moreover, Coumadin necrosis, Heparin necrosis and Calciphylaxis are diseases for which no therapies are proven beneficial. This offers an area of unmet needs where market players can develop a molecule and form a strong position in the dermal necrosis treatment market. TISSEEL Kit, from Baxter is an example of device which is used for management of skin necrosis and mucosal ulcers. The device is a two-component fibrin sealant offers highly concentrated human fibrinogen to seal tissue and stop diffuse bleeding.

Market Analysis and Insights: Global Dermal Necrosis Treatment Market
The global Dermal Necrosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Dermal Necrosis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Dermal Necrosis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Dermal Necrosis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Dermal Necrosis Treatment market.

Global Dermal Necrosis Treatment Scope and Market Size
Dermal Necrosis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Dermal Necrosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Immunosuppressive Agents
Corticosteroids

Segment by Application
Hospital
Clinics
Ambulatory Surgery Center

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Baxter
Boston Therapeutics
Amgen
AstraZeneca
Glaxo Smithkline Pharmaceuticals
Systopic Laboratories
Sun Pharmaceuticals
RPG Life Sciences
Zydus Cadila

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Dermal Necrosis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Immunosuppressive Agents
1.2.3 Corticosteroids
1.3 Market by Application
1.3.1 Global Dermal Necrosis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Ambulatory Surgery Center
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Dermal Necrosis Treatment Market Perspective (2016-2027)
2.2 Dermal Necrosis Treatment Growth Trends by Regions
2.2.1 Dermal Necrosis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Dermal Necrosis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Dermal Necrosis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Dermal Necrosis Treatment Industry Dynamic
2.3.1 Dermal Necrosis Treatment Market Trends
2.3.2 Dermal Necrosis Treatment Market Drivers
2.3.3 Dermal Necrosis Treatment Market Challenges
2.3.4 Dermal Necrosis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Dermal Necrosis Treatment Players by Revenue
3.1.1 Global Top Dermal Necrosis Treatment Players by Revenue (2016-2021)
3.1.2 Global Dermal Necrosis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Dermal Necrosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Dermal Necrosis Treatment Revenue
3.4 Global Dermal Necrosis Treatment Market Concentration Ratio
3.4.1 Global Dermal Necrosis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Dermal Necrosis Treatment Revenue in 2020
3.5 Dermal Necrosis Treatment Key Players Head office and Area Served
3.6 Key Players Dermal Necrosis Treatment Product Solution and Service
3.7 Date of Enter into Dermal Necrosis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Dermal Necrosis Treatment Breakdown Data by Type
4.1 Global Dermal Necrosis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Dermal Necrosis Treatment Forecasted Market Size by Type (2022-2027)

5 Dermal Necrosis Treatment Breakdown Data by Application
5.1 Global Dermal Necrosis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Dermal Necrosis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Dermal Necrosis Treatment Market Size (2016-2027)
6.2 North America Dermal Necrosis Treatment Market Size by Type
6.2.1 North America Dermal Necrosis Treatment Market Size by Type (2016-2021)
6.2.2 North America Dermal Necrosis Treatment Market Size by Type (2022-2027)
6.2.3 North America Dermal Necrosis Treatment Market Size by Type (2016-2027)
6.3 North America Dermal Necrosis Treatment Market Size by Application
6.3.1 North America Dermal Necrosis Treatment Market Size by Application (2016-2021)
6.3.2 North America Dermal Necrosis Treatment Market Size by Application (2022-2027)
6.3.3 North America Dermal Necrosis Treatment Market Size by Application (2016-2027)
6.4 North America Dermal Necrosis Treatment Market Size by Country
6.4.1 North America Dermal Necrosis Treatment Market Size by Country (2016-2021)
6.4.2 North America Dermal Necrosis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Dermal Necrosis Treatment Market Size (2016-2027)
7.2 Europe Dermal Necrosis Treatment Market Size by Type
7.2.1 Europe Dermal Necrosis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Dermal Necrosis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Dermal Necrosis Treatment Market Size by Type (2016-2027)
7.3 Europe Dermal Necrosis Treatment Market Size by Application
7.3.1 Europe Dermal Necrosis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Dermal Necrosis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Dermal Necrosis Treatment Market Size by Application (2016-2027)
7.4 Europe Dermal Necrosis Treatment Market Size by Country
7.4.1 Europe Dermal Necrosis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Dermal Necrosis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Dermal Necrosis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Dermal Necrosis Treatment Market Size by Type
8.2.1 Asia-Pacific Dermal Necrosis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Dermal Necrosis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Dermal Necrosis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Dermal Necrosis Treatment Market Size by Application
8.3.1 Asia-Pacific Dermal Necrosis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Dermal Necrosis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Dermal Necrosis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Dermal Necrosis Treatment Market Size by Region
8.4.1 Asia-Pacific Dermal Necrosis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Dermal Necrosis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Dermal Necrosis Treatment Market Size (2016-2027)
9.2 Latin America Dermal Necrosis Treatment Market Size by Type
9.2.1 Latin America Dermal Necrosis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Dermal Necrosis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Dermal Necrosis Treatment Market Size by Type (2016-2027)
9.3 Latin America Dermal Necrosis Treatment Market Size by Application
9.3.1 Latin America Dermal Necrosis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Dermal Necrosis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Dermal Necrosis Treatment Market Size by Application (2016-2027)
9.4 Latin America Dermal Necrosis Treatment Market Size by Country
9.4.1 Latin America Dermal Necrosis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Dermal Necrosis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Dermal Necrosis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Dermal Necrosis Treatment Market Size by Type
10.2.1 Middle East & Africa Dermal Necrosis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Dermal Necrosis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Dermal Necrosis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Dermal Necrosis Treatment Market Size by Application
10.3.1 Middle East & Africa Dermal Necrosis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Dermal Necrosis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Dermal Necrosis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Dermal Necrosis Treatment Market Size by Country
10.4.1 Middle East & Africa Dermal Necrosis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Dermal Necrosis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Baxter
11.1.1 Baxter Company Details
11.1.2 Baxter Business Overview
11.1.3 Baxter Dermal Necrosis Treatment Introduction
11.1.4 Baxter Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.1.5 Baxter Recent Development
11.2 Boston Therapeutics
11.2.1 Boston Therapeutics Company Details
11.2.2 Boston Therapeutics Business Overview
11.2.3 Boston Therapeutics Dermal Necrosis Treatment Introduction
11.2.4 Boston Therapeutics Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.2.5 Boston Therapeutics Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Dermal Necrosis Treatment Introduction
11.3.4 Amgen Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Dermal Necrosis Treatment Introduction
11.4.4 AstraZeneca Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Glaxo Smithkline Pharmaceuticals
11.5.1 Glaxo Smithkline Pharmaceuticals Company Details
11.5.2 Glaxo Smithkline Pharmaceuticals Business Overview
11.5.3 Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Introduction
11.5.4 Glaxo Smithkline Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.5.5 Glaxo Smithkline Pharmaceuticals Recent Development
11.6 Systopic Laboratories
11.6.1 Systopic Laboratories Company Details
11.6.2 Systopic Laboratories Business Overview
11.6.3 Systopic Laboratories Dermal Necrosis Treatment Introduction
11.6.4 Systopic Laboratories Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.6.5 Systopic Laboratories Recent Development
11.7 Sun Pharmaceuticals
11.7.1 Sun Pharmaceuticals Company Details
11.7.2 Sun Pharmaceuticals Business Overview
11.7.3 Sun Pharmaceuticals Dermal Necrosis Treatment Introduction
11.7.4 Sun Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.7.5 Sun Pharmaceuticals Recent Development
11.8 RPG Life Sciences
11.8.1 RPG Life Sciences Company Details
11.8.2 RPG Life Sciences Business Overview
11.8.3 RPG Life Sciences Dermal Necrosis Treatment Introduction
11.8.4 RPG Life Sciences Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.8.5 RPG Life Sciences Recent Development
11.9 Zydus Cadila
11.9.1 Zydus Cadila Company Details
11.9.2 Zydus Cadila Business Overview
11.9.3 Zydus Cadila Dermal Necrosis Treatment Introduction
11.9.4 Zydus Cadila Revenue in Dermal Necrosis Treatment Business (2016-2021)
11.9.5 Zydus Cadila Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Dermal Necrosis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Immunosuppressive Agents
Table 3. Key Players of Corticosteroids
Table 4. Global Dermal Necrosis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Dermal Necrosis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Dermal Necrosis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Dermal Necrosis Treatment Market Share by Regions (2016-2021)
Table 8. Global Dermal Necrosis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Dermal Necrosis Treatment Market Share by Regions (2022-2027)
Table 10. Dermal Necrosis Treatment Market Trends
Table 11. Dermal Necrosis Treatment Market Drivers
Table 12. Dermal Necrosis Treatment Market Challenges
Table 13. Dermal Necrosis Treatment Market Restraints
Table 14. Global Dermal Necrosis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Dermal Necrosis Treatment Market Share by Players (2016-2021)
Table 16. Global Top Dermal Necrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Necrosis Treatment as of 2020)
Table 17. Ranking of Global Top Dermal Necrosis Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Dermal Necrosis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Dermal Necrosis Treatment Product Solution and Service
Table 21. Date of Enter into Dermal Necrosis Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Dermal Necrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Dermal Necrosis Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Dermal Necrosis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Dermal Necrosis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Dermal Necrosis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Dermal Necrosis Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Dermal Necrosis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Dermal Necrosis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Dermal Necrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Dermal Necrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Dermal Necrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Dermal Necrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Dermal Necrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Dermal Necrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Dermal Necrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Dermal Necrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Dermal Necrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Dermal Necrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Dermal Necrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Dermal Necrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Dermal Necrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Dermal Necrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Dermal Necrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Dermal Necrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Dermal Necrosis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Dermal Necrosis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Dermal Necrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Dermal Necrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Dermal Necrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Dermal Necrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Dermal Necrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Dermal Necrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Dermal Necrosis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Dermal Necrosis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Dermal Necrosis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Dermal Necrosis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Dermal Necrosis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Dermal Necrosis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Baxter Company Details
Table 62. Baxter Business Overview
Table 63. Baxter Dermal Necrosis Treatment Product
Table 64. Baxter Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 65. Baxter Recent Development
Table 66. Boston Therapeutics Company Details
Table 67. Boston Therapeutics Business Overview
Table 68. Boston Therapeutics Dermal Necrosis Treatment Product
Table 69. Boston Therapeutics Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 70. Boston Therapeutics Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Dermal Necrosis Treatment Product
Table 74. Amgen Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. AstraZeneca Company Details
Table 77. AstraZeneca Business Overview
Table 78. AstraZeneca Dermal Necrosis Treatment Product
Table 79. AstraZeneca Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 80. AstraZeneca Recent Development
Table 81. Glaxo Smithkline Pharmaceuticals Company Details
Table 82. Glaxo Smithkline Pharmaceuticals Business Overview
Table 83. Glaxo Smithkline Pharmaceuticals Dermal Necrosis Treatment Product
Table 84. Glaxo Smithkline Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 85. Glaxo Smithkline Pharmaceuticals Recent Development
Table 86. Systopic Laboratories Company Details
Table 87. Systopic Laboratories Business Overview
Table 88. Systopic Laboratories Dermal Necrosis Treatment Product
Table 89. Systopic Laboratories Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 90. Systopic Laboratories Recent Development
Table 91. Sun Pharmaceuticals Company Details
Table 92. Sun Pharmaceuticals Business Overview
Table 93. Sun Pharmaceuticals Dermal Necrosis Treatment Product
Table 94. Sun Pharmaceuticals Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 95. Sun Pharmaceuticals Recent Development
Table 96. RPG Life Sciences Company Details
Table 97. RPG Life Sciences Business Overview
Table 98. RPG Life Sciences Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 99. RPG Life Sciences Recent Development
Table 100. Zydus Cadila Company Details
Table 101. Zydus Cadila Business Overview
Table 102. Zydus Cadila Dermal Necrosis Treatment Product
Table 103. Zydus Cadila Revenue in Dermal Necrosis Treatment Business (2016-2021) & (US$ Million)
Table 104. Zydus Cadila Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Dermal Necrosis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Immunosuppressive Agents Features
Figure 3. Corticosteroids Features
Figure 4. Global Dermal Necrosis Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgery Center Case Studies
Figure 8. Dermal Necrosis Treatment Report Years Considered
Figure 9. Global Dermal Necrosis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Dermal Necrosis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dermal Necrosis Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Dermal Necrosis Treatment Market Share by Regions (2022-2027)
Figure 13. Global Dermal Necrosis Treatment Market Share by Players in 2020
Figure 14. Global Top Dermal Necrosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermal Necrosis Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Dermal Necrosis Treatment Revenue in 2020
Figure 16. Global Dermal Necrosis Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Dermal Necrosis Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Dermal Necrosis Treatment Market Share by Type (2016-2027)
Figure 20. North America Dermal Necrosis Treatment Market Share by Application (2016-2027)
Figure 21. North America Dermal Necrosis Treatment Market Share by Country (2016-2027)
Figure 22. United States Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Dermal Necrosis Treatment Market Share by Type (2016-2027)
Figure 26. Europe Dermal Necrosis Treatment Market Share by Application (2016-2027)
Figure 27. Europe Dermal Necrosis Treatment Market Share by Country (2016-2027)
Figure 28. Germany Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Dermal Necrosis Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Dermal Necrosis Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Dermal Necrosis Treatment Market Share by Region (2016-2027)
Figure 38. China Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Dermal Necrosis Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Dermal Necrosis Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Dermal Necrosis Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Dermal Necrosis Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Dermal Necrosis Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Dermal Necrosis Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Dermal Necrosis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Baxter Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 58. Boston Therapeutics Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 59. Amgen Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 60. AstraZeneca Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 61. Glaxo Smithkline Pharmaceuticals Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 62. Systopic Laboratories Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 63. Sun Pharmaceuticals Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 64. RPG Life Sciences Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 65. Zydus Cadila Revenue Growth Rate in Dermal Necrosis Treatment Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[皮膚壊死治療の世界市場規模・現状・予測2021年-2027年] (Global Dermal Necrosis Treatment Market Size, Status and Forecast 2021-2027 / QY21APR1802)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆